Financhill
Back

POET Technologies Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
15

POET
POET Technologies

Last Price:
1.73
Seasonality Move:
-11.16%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
15
POET Technologies (POET) is a Sell

Is POET Technologies a Buy, Sell or Hold?

  • The current POET Technologies [POET] share price is $1.75. The Score for POET is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • POET is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

POET Stock Price Chart

What is POET Technologies's stock price today?

  • The POET Technologies share price today is $1.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and POET is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

POET Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 45.21 Sell
Chaikin Money Flow: -26321 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.7 - 2) Sell
Bollinger Bands (100): (1.19 - 2.05) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

POET Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.82 Sell
20-day SMA: 1.8 Sell
50-day SMA: 1.92 Sell
200-day SMA: 1.74 Buy
8-day EMA: 1.82 Sell
20-day EMA: 1.84 Sell
50-day EMA: 1.82 Sell
200-day EMA: 2.01 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

POET Technologies Earnings Growth & POET Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.05 per share, an increase this year of $0.11 per share, and an increase next year of $0.25 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

POET Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):